Skip to main content

abrdn Life Sciences Investors

Closed-end
Registrant
abrdn Life Sciences Investors
Class ticker
HQL
Net Assets
$689,248,803
Holdings
158
Latest Report
Jun 30, 2026

Net Assets Over Time

Holdings · 158

Export CSV
Showing 1–50 of 158 holdings by value · page 1 of 4
Holding Balance Value % of Fund Open
uniQure NV
564,239 $25,988,848 3.77%
VERADERMICS, INC.
109,305 $13,437,957 1.95%
Crinetics Pharmaceuticals Inc
312,153 $11,680,765 1.69%
NEUROVANCE MILESTONE INTEREST
34,055 $11,413,530 1.66%
Newamsterdam Pharma Co NV
244,176 $8,275,125 1.20%
State Street Global Advisors
6,953,413 $6,953,413 1.01%
IMMUNIC
444,460 $6,831,356 0.99%
Biohaven Ltd
365,519 $5,438,923 0.79%

Showing the top 50 of 158 holdings. Create a free account to see every holding and download the CSV.